Molecular determinants of epistasis in HIV-1 protease: Elucidating the interdependence of L89V and L90M mutations in resistance

Protease inhibitors have the highest potency among antiviral therapies against HIV-1 infections, yet the virus can evolve resistance. Darunavir (DRV), currently the most potent FDA approved protease inhibitor, retains potency against single site mutations. However, complex combinations of mutations...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biochemistry
Main Authors: Henes, Mina, Kosovrasti, Klajdi, Lockbaum, Gordon J., Leidner, Florian, Nachum, Gily S., Nalivaika, Ellen A., Bolon, Daniel N.A., Yilmaz, Nese Kurt, Schiffer, Celia A., Whitfield, Troy W.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6941756/
https://ncbi.nlm.nih.gov/pubmed/31386353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biochem.9b00446
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker